SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Nabi (NABI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jeff Dutter who wrote (156)5/12/1997 7:32:00 PM
From: The BayWatcher   of 354
 
NEWS FLASH: The June 1997 issue of Individual
Investor takes a look at NABI and rates it 2 BULLS,
which they define as "TAKE A STAKE." Their rating
system goes from 3 Bulls (highest rating_ to 3
Bears (lowest rating). In the article they quote
the analyst for Southeast Research Partners who has
a 12 month target of 12. Individual Investor
wrote" "Investors should consider the current price
dip as a buying opportunity." They also note that
NABI has $27 million in cash and a $20 million
credit line, which they say is plenty of money to
finance the 11 drugs in its clinical pipeline.
Guri was quoted as saying that the market reaction
re: HIV-IG was larger than is justified. This
positive news should move us a bit uoward.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext